Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |